News | Artificial Intelligence | November 18, 2021

VIDA Intelligence Portal, now part of VIDA Discovery, eases clinical trial imaging, bringing AI to the cloud

VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of a new artificial intelligence (AI)-powered portal. The cloud-based VIDA Intelligence Portal (VIP) streamlines challenges often associated with imaging in trials such as site onboarding, staff training, image data management, and data quality.

November 18, 2021 — VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of a new artificial intelligence (AI)-powered portal. The cloud-based VIDA Intelligence Portal (VIP) streamlines challenges often associated with imaging in trials such as site onboarding, staff training, image data management, and data quality. Leveraging a powerful AI engine, the portal automates cumbersome and time sensitive tasks such as subject anonymization and quality control workflow processes.

Clinical trial operations are challenging—80% of trials face delays and 11% of trial sites never enroll a single patient. Respiratory trials that involve imaging are even more difficult due to the complexities involved in proper image acquisition, subject breathing training, image reconstruction, motion artifacts, secure data exchange, and more. VIP allays these issues by automatically applying AI prior to human interaction, allowing for immediate intervention in the event of poor data quality, for example. The result is smoother trials that produce high quality data, leading to more efficient and successful outcomes. 

With VIP, available broadly as part of VIDA Discovery, trial sponsors and sites can effortlessly manage scans and related information, eliminating manual steps that often slow trials and can affect data integrity. The highly secure portal serves as a centralized information hub, replacing a patchwork of existing online and offline third-party solutions.

“Our aim is to help sites and sponsors use the power of AI to analyze data for consistency and generate new categories of lung biomarkers. We’re excited to see sites already realizing this promise as well as experiencing more efficient trial imaging operations,” said Todd Johnson, VIDA’s chief technology officer. “The VIDA Intelligence Portal also provides a foundation for future innovations we can’t wait to deliver.”

As the leader in respiratory/lung imaging and generation of biomarker insights, VIDA’s rapidly growing clinical data lake is now being leveraged to solve many problems often associated with complex imaging in clinical trials. For example, VIDA's analysis is helping trial sponsors and sites identify future trial participants or provide access to aggregated data intelligence for future drug studies.

VIDA will demo the portal during the Radiological Society of North America (RSNA) annual meeting, which brings together the world’s leading radiologists and healthcare system executives, Nov. 28 – Dec. 1, at Booth #4351. CTO Todd Johnson will speak on Tuesday, Nov. 30 at 12 noon CST as part of the AI Showcase about the role the portal plays in improving clinical trial and AI ROI.

For more information: https://vidalung.ai

Additional RSNA21 conference coverage can be found here.


Related Content

News | Computed Tomography (CT)

January 30, 2023 — Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while ...

Time January 30, 2023
arrow
Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
arrow
Videos | PACS

Konica Minolta Healthcare recently announced it is working with Amazon Web Services to offer its cloud-based Exa ...

Time January 27, 2023
arrow
News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
arrow
News | Artificial Intelligence

Artificial intelligence (AI) is playing a growing role in all our lives and has shown promise in addressing some of the ...

Time January 26, 2023
arrow
News | Digital Pathology

January 25, 2023 — mTuitive, Inc. and PathPresenter Corporation announced a new partnership to deliver an enhanced ...

Time January 25, 2023
arrow
News | Breast Imaging

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

Time January 24, 2023
arrow
News | Digital Radiography (DR)

January 24, 2023 — Carestream Health was awarded 20 new patents in 2022 for global advances in artificial intelligence ...

Time January 24, 2023
arrow
News | Radiology Imaging

January 23, 2023 — Canon Medical Systems has released a new eBook featuring its new medical imaging roadshow. This new ...

Time January 23, 2023
arrow
Videos | Cardiac Imaging

Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val ...

Time January 23, 2023
arrow
Subscribe Now